111Boehringer_Ingelheim_Logo_RGB_Dark_Green (002).png
SPEVIGO® approved for expanded indications in China and the US
March 19, 2024 07:00 ET | Boehringer Ingelheim
Generalized pustular psoriasis (GPP) is a rare, chronic, heterogenous neutrophilic inflammatory disease associated with skin and systemic symptoms, such as fever, pain, and fatigue1,2,3,4In China,...